{"pmid":32278616,"title":"Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients.","text":["Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients.","The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many uncertainties remain, especially in the kidney transplant population. This manuscript presents a proposal for action with general and specific recommendations to protect and prevent infection in this vulnerable population such as kidney transplant recipients.","Nefrologia","Lopez, Veronica","Vazquez, Teresa","Alonso-Titos, Juana","Cabello, Mercedes","Alonso, Angel","Beneyto, Isabel","Crespo, Marta","Diaz-Corte, Carmen","Franco, Antonio","Gonzalez-Roncero, Francisco","Gutierrez, Elena","Guirado, Luis","Jimenez, Carlos","Jironda, Cristina","Lauzurica, Ricardo","Llorente, Santiago","Mazuecos, Auxiliadora","Paul, Javier","Rodriguez-Benot, Alberto","Ruiz, Juan Carlos","Sanchez-Fructuoso, Ana","Sola, Eugenia","Torregrosa, Vicente","Zarraga, Sofia","Hernandez, Domingo","32278616"],"abstract":["The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many uncertainties remain, especially in the kidney transplant population. This manuscript presents a proposal for action with general and specific recommendations to protect and prevent infection in this vulnerable population such as kidney transplant recipients."],"journal":"Nefrologia","authors":["Lopez, Veronica","Vazquez, Teresa","Alonso-Titos, Juana","Cabello, Mercedes","Alonso, Angel","Beneyto, Isabel","Crespo, Marta","Diaz-Corte, Carmen","Franco, Antonio","Gonzalez-Roncero, Francisco","Gutierrez, Elena","Guirado, Luis","Jimenez, Carlos","Jironda, Cristina","Lauzurica, Ricardo","Llorente, Santiago","Mazuecos, Auxiliadora","Paul, Javier","Rodriguez-Benot, Alberto","Ruiz, Juan Carlos","Sanchez-Fructuoso, Ana","Sola, Eugenia","Torregrosa, Vicente","Zarraga, Sofia","Hernandez, Domingo"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278616","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.nefro.2020.03.002","keywords":["Covid-19","Immunosuppressed","Inmunodeprimido","Kidney transplantation","SARS-CoV-2","Trasplante renal"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663890921959194624,"score":7.9164424,"similar":[{"pmid":32279418,"title":"Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).","text":["Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).","During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case-report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy.","Transpl Infect Dis","Bartiromo, Marilu","Borchi, Beatrice","Botta, Annarita","Bagala, Alfredo","Lugli, Gianmarco","Tilli, Marta","Cavallo, Annalisa","Xhaferi, Brunilda","Cutruzzula, Roberta","Vaglio, Augusto","Bresci, Silvia","Larti, Aida","Bartoloni, Alessandro","Cirami, Calogero","32279418"],"abstract":["During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case-report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy."],"journal":"Transpl Infect Dis","authors":["Bartiromo, Marilu","Borchi, Beatrice","Botta, Annarita","Bagala, Alfredo","Lugli, Gianmarco","Tilli, Marta","Cavallo, Annalisa","Xhaferi, Brunilda","Cutruzzula, Roberta","Vaglio, Augusto","Bresci, Silvia","Larti, Aida","Bartoloni, Alessandro","Cirami, Calogero"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279418","week":"202016|Apr 13 - Apr 19","doi":"10.1111/tid.13286","keywords":["COVID-19","drug-drug interaction","kidney transplant"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663890921989603328,"score":231.5934},{"pmid":32277387,"title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","text":["Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.","Hepatol Int","Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George","32277387"],"abstract":["Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic."],"journal":"Hepatol Int","authors":["Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277387","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10043-z","keywords":["2019-nCoV","COVID-19","Liver transplantation","Management"],"source":"PubMed","locations":["Beijing","China","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1663798882904047616,"score":218.53168},{"pmid":32243672,"title":"SARS Cov2 infection in a renal transplanted patients. A case report.","text":["SARS Cov2 infection in a renal transplanted patients. A case report.","The clinical manifestation of COVID-19 can vary from an asymptomatic course to ARDS requiring invasive mechanical ventilation and extracorporeal membrane oxygenation. A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression. It is possible that Immunosuppression can \"be protective\" as the cytokine storm is an important factor in the disease story. Despite the good outcome reported in the present case report, is remains of vital importance the solid organ transplant patients use precautions in order to avoid the infection.","Am J Transplant","Seminari, Elena","Colaneri, Marta","Sambo, Margherita","Gallazzi, Ilaria","Di Matteo, Angela","Silvia, Roda","Bruno, Raffaele","32243672"],"abstract":["The clinical manifestation of COVID-19 can vary from an asymptomatic course to ARDS requiring invasive mechanical ventilation and extracorporeal membrane oxygenation. A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression. It is possible that Immunosuppression can \"be protective\" as the cytokine storm is an important factor in the disease story. Despite the good outcome reported in the present case report, is remains of vital importance the solid organ transplant patients use precautions in order to avoid the infection."],"journal":"Am J Transplant","authors":["Seminari, Elena","Colaneri, Marta","Sambo, Margherita","Gallazzi, Ilaria","Di Matteo, Angela","Silvia, Roda","Bruno, Raffaele"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243672","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15902","source":"PubMed","locations":["Cov2"],"topics":["Case Report"],"weight":1,"_version_":1663352135807401984,"score":189.79385},{"pmid":32249089,"title":"Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.","text":["Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.","Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy.","Eur Urol","Zhang, Hui","Chen, Yan","Yuan, Quan","Xia, Qiu-Xiang","Zeng, Xian-Peng","Peng, Jing-Tao","Liu, Jing","Xiao, Xing-Yuan","Jiang, Guo-Song","Xiao, Han-Yu","Xie, Liang-Bo","Chen, Jing","Liu, Jia-Li","Xiao, Xiong","Su, Hua","Zhang, Chun","Zhang, Xiao-Ping","Yang, Hua","Li, Heng","Wang, Zhen-Di","32249089"],"abstract":["Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy."],"journal":"Eur Urol","authors":["Zhang, Hui","Chen, Yan","Yuan, Quan","Xia, Qiu-Xiang","Zeng, Xian-Peng","Peng, Jing-Tao","Liu, Jing","Xiao, Xing-Yuan","Jiang, Guo-Song","Xiao, Han-Yu","Xie, Liang-Bo","Chen, Jing","Liu, Jia-Li","Xiao, Xiong","Su, Hua","Zhang, Chun","Zhang, Xiao-Ping","Yang, Hua","Li, Heng","Wang, Zhen-Di"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249089","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.eururo.2020.03.030","keywords":["Clinical feature","Coronavirus disease 2019","Kidney transplant recipient"],"source":"PubMed","locations":["myalgia","fatigue"],"topics":["Case Report"],"weight":1,"e_drugs":["Creatinine","Nitrogen","Urea"],"_version_":1663352136235220994,"score":188.38126},{"pmid":32181990,"title":"Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.","text":["Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.","The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia.","Am J Transplant","Zhu, Lan","Xu, Xizhen","Ma, Ke","Yang, Junling","Guan, Hanxiong","Chen, Song","Chen, Zhishui","Chen, Gang","32181990"],"abstract":["The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia."],"journal":"Am J Transplant","authors":["Zhu, Lan","Xu, Xizhen","Ma, Ke","Yang, Junling","Guan, Hanxiong","Chen, Song","Chen, Zhishui","Chen, Gang"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32181990","week":"202012|Mar 16 - Mar 22","doi":"10.1111/ajt.15869","keywords":["COVID-19","coronavirus","immunosuppression","pneumonia","renal transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"e_drugs":["Methylprednisolone"],"_version_":1663352133831884801,"score":188.31087}]}